With Mayo Clinic BioPharma Diagnostics, you have access to Mayo Clinic Laboratories' expansive clinical test menu, including more than 3,800 tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored testing programs, availing unparalleled testing expertise to our biopharma partners.
Our dedicated CAP-affiliated laboratory directors are board-certified physicians and clinical laboratory scientists who engage in clinical practice as well as research. Bringing clinical experience to the test development arena enables evidence-based innovation rooted in patient outcomes. A partnership with BioPharma Diagnostics provides partners with access to a vast testing library as well as a wealth of patient-centric expertise to optimize clinical trial and drug development.
BioPharma Diagnostics offers access to some of the world’s most esoteric and advanced neurologic testing. Our assays span the neurologic disease spectrum and include genetic and biochemical biomarker evaluations for Alzheimer’s disease; extensive offerings to evaluate for autoimmune neurologic disorders; next-generation sequencing to identify neurogenetic illness; and other assays.
With more than 330 tests in our gastroenterology test catalog, our GI testing plays a key role in establishing Mayo Clinic as the nation's leading gastroenterology and GI surgery hospital. From routine serological testing to specialized fecal testing to advanced biomarker evaluations, our testing menu offers an array of methodologies to test and guide treatment for a range of GI disorders.
Performing more than three million tests annually, our infectious disease and clinical microbiology laboratories have developed and implemented innovative in vitro and culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular models for rapid detection, identification, and characterization of microbes. Our comprehensive testing menu offers a broad selection of tests for rapid identification and in-depth characterization of the causative agents of infectious disease.
Mayo Clinic’s extensive oncology test menu features a broad range of biomarker testing to assist with determining diagnosis and treatment effectivity across the full spectrum of solid tumor malignancies. From single gene and tumor-specific genetic panels to MayoComplete — which evaluates 514 genes — to immune profiling, our oncology assays are developed and validated in collaboration with Mayo Clinic oncologists, pathologists, geneticists, and laboratorians.
We offer a robust library of expert-backed hematology evaluations designed to improve outcomes, increase efficiency, and decrease costs. Our hematology testing laboratories are led by board-certiﬁed hematologists and hematopathologists who focus on molecular diagnostics and prognostics of hematologic disorders.
Affecting 25 million to 30 million Americans and manifesting in as many as 7,000 different forms, the cumulative impact of rare diseases is huge. Our genetic testing was developed by geneticists, genetic counselors, laboratory scientists, and bioinformaticians and employs a variety of genetic sequencing techniques to identify and confirm rare disease.